EpiPen 2-Pak (Epinephrine) Auto-Injectors 0.3 mg, Rx only, Manufactured for Mylan Specialty L.P., Morgantown WV 26505 by Meridian Medical Technologies, Inc., Columbia, MD 21046, a Pfizer company; NDC 49502-500-02 ---- ALSO LABELED OUTSIDE THE US AS ---- Epipen Auto-Injector 0.3 mg -Bright Stock labeled for multiple countries- manufactured for Mylan by Meridian Medical Technologies, Inc., Columbia, MD 21046, a Pfizer company.
Publicado el 10 de mayo de 2017 · Inicio del retiro: 12 de marzo de 2017
Resumen
FDA registra el retiro D-0690-2017 de medicamentos de Clase I, publicado el 10 de mayo de 2017 e iniciado el 12 de marzo de 2017. Empresa responsable: Meridian Medical Technologies a Pfizer Company; Estado: En curso; Cantidad reportada: 373,960 2-paks (U.S.) ; 331,738 auto-injectors (O.U.S.); Lote: US: lot 5GM631, exp. April 2017; lot 5GM640, exp. May 2017; lot 6GM072, exp. Sep 2017; lot 6GM082, exp. Sep 2017; lot 6GM088, exp. Oct 2017; lot 6GM087, exp. Oct 2017; lot 6GM198, exp. Oct 2017; lot 6GM081, exp. Sep 2017; lot 6GM091, exp. Oct 2017; lot 6GM199, exp. Oct 2017: INTERNATIONAL: lot 5FA665, exp. April 2017; lot 5GU763, exp. May 2017; lot 6FA293, exp. Oct 2017; lot 6FA292, exp. Oct 2017; lot 6GH294, exp. Oct 2017. La Clase I indica una probabilidad razonable de consecuencias graves para la salud o muerte.
Estado reportado al momento de publicación: Ongoing — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
Defective Delivery System; reports of the device failing to activate which could result in a patient not receiving medication
Qué hacer
Voluntary: Firm initiated · Press Release
Recibe un correo si EPIPEN vuelve a tener un retiro
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Marca
- EPIPEN
- Fabricante
- Meridian Medical Technologies a Pfizer Company
- Distribuidor
- Nationwide and Puerto Rico, Argentina, Austria, Australia, Belgium, Chile, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Ireland, Italy, Japan, Latvia, Lithuania, Netherlands, New Zealand, Norway, Poland, Portugal, Romania, Saudi Arabia, Singapore, Slovakia, Slovenia, Sweden, Switzerland, Taiwan, Thailand, United Kingdom. There has been no U.S. government or military distribution.
- Lote
- US: lot 5GM631, exp. April 2017; lot 5GM640, exp. May 2017; lot 6GM072, exp. Sep 2017; lot 6GM082, exp. Sep 2017; lot 6GM088, exp. Oct 2017; lot 6GM087, exp. Oct 2017; lot 6GM198, exp. Oct 2017; lot 6GM081, exp. Sep 2017; lot 6GM091, exp. Oct 2017; lot 6GM199, exp. Oct 2017: INTERNATIONAL: lot 5FA665, exp. April 2017; lot 5GU763, exp. May 2017; lot 6FA293, exp. Oct 2017; lot 6FA292, exp. Oct 2017; lot 6GH294, exp. Oct 2017.
- Clasificación de riesgo
- Class I
- Área (FDA)
- drug
- País
- United States
Retiros relacionados
- FDAEPI-Pen Jr, 2-PAK, (epinephrine injection, USP) Single-Dose Auto-Injectors 0.15 mg, packaged in 2 count15 de junio de 2022
- FDAEPI-PEN 2-PAK (epinephrine injection, USP), Single-Dose Auto-Injectors 0.3 mg, Rx only, Manufactured for:15 de junio de 2022
- FDAEpinephrine Injection, USP Auto-Injectors in all strengths, packs and styles Manufactured for Mylan Specialty2 de junio de 2021
- FDAEpiPen Jr. 2-Pak (Epinephrine) Auto-Injectors 0.15 mg, Rx only, Manufactured for Mylan Specialty L.P.,10 de mayo de 2017
- FDAFluconazole Tablets, USP, 200 mg, 100-count Unit Dose carton, Rx only, Manufactured by Dr. Reddy's10 de mayo de 2017
- FDAFluconazole Tablets, USP, 100 mg, 100-count Unit Dose carton, Rx only, Manufactured by Dr. Reddy's10 de mayo de 2017
Preguntas sobre este retiro
¿EpiPen 2-Pak (Epinephrine) Auto-Injectors 0.3 mg, Rx only, Manufactured for Mylan Specialty L.P., Morgantown WV 26505 by Meridian Medical Technologies, Inc., Columbia, MD 21046, a Pfizer company; NDC 49502-500-02 ---- ALSO LABELED OUTSIDE THE US AS ---- Epipen Auto-Injector 0.3 mg -Bright Stock labeled for multiple countries- manufactured for Mylan by Meridian Medical Technologies, Inc., Columbia, MD 21046, a Pfizer company. fue retirado del mercado?
Sí. FDA publicó el retiro D-0690-2017 el 10 de mayo de 2017. Peligro reportado: Defective Delivery System; reports of the device failing to activate which could result in a patient not receiving medication
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Press Release
¿Cómo sé si mi unidad está incluida en el retiro?
Compara los datos de tu producto con los del aviso. Marca: EPIPEN.